Don Healey - Jan 24, 2024 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role: Chief Technology Officer
Signature: /s/ Nick Harvey, Attorney-in-Fact
Stock symbol: ACET
Transactions as of: Jan 24, 2024
Transactions value $: -$11,688
Form type: 4
Date filed: 1/26/2024, 07:09 PM
Previous filing: Oct 3, 2023
Next filing: Jun 7, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACET	Common Stock	Tax liability	-$11.7K	-4.87K	-8.47%	$2.40	52.6K	Jan 24, 2024	Direct	F1
transaction	ACET	Common Stock	Award	$0	+19.7K	+37.43%	$0.00	72.3K	Jan 24, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ACET	Stock Option (Right to Buy)	Award	$0	+212K		$0.00	212K	Jan 24, 2024	Common Stock	212K	$2.40	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.
F2	The Reporting Person was issued RSUs. Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest in three (3) annual installments, with the first tranche vesting on January 24, 2025. The RSUs may be settled only by delivering shares of Common Stock, and thus, the grant is being reported in Table I as allowed per SEC guidance.
F3	1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.